Antibody Production Market by Type (Polyclonal Antibody, Monoclonal Antibody), by Process (Upstream Processing, Downstream Processing, Filtration), by End-Use and Segment Forecasts, 2014 - 2025

  • ID: 4209719
  • Report
  • 90 pages
  • Grand View Research
1 of 6

FEATURED COMPANIES

  • Cellab GmbH
  • Eppendorf AG
  • GE Healthcare
  • INTEGRA Biosciences AG
  • Merck KGaA
  • Pall Corp.
  • MORE
The global antibody production market is expected to reach a value of USD 22.6 billion by 2025. Increasing demand for therapeutic antibodies including monoclonal and polyclonal antibodies is a major factor that drives growth of the market during forecast period. Antibodies are the dominant biopharmaceuticals that specifically target the abnormal cells. Thus, many pharmaceuticals and biotechnology companies have begun to focus on the development of advanced antibodies for the treatment of chronic diseases such as cancer, rheumatic heart disease, and arthritis.

Patent expiry of several blockbuster monoclonal antibodies in the near future, is another major factor supporting the growth of the antibody production market. Several antibodies such as Avastin, Herceptin, and Mabthera are going to lose their patents in a few years. For instance, the patent of Herceptin (trastuzumab) expired in Europe in July 2014 and will expire in the U.S. in June 2019. Many companies such as Amgen Inc., Synthon, Biocon, and Pfizer Inc. are developing biosimilar for trastuzumab, which is expected to propel the demand for antibody production products.

Further key findings from the study suggest:

Downstream processing was the largest revenue-grossing segment of the antibody production market in 2016. It is also expected to exhibit the highest CAGR during the forecast period, owing to large application of chromatography devices and resins in downstream processing

The monoclonal antibody segment was leading in 2016, due to its higher demand in treatment of chronic diseases including cancer, blood disorders, and growth hormone deficiency

The pharmaceutical and biotechnology companies segment dominated the overall market in terms of revenue in 2016, owing to the large production of therapeutic antibodies and high investment in R&D by companies for drug development

North America was the largest revenue-generating region of the market in the year 2016. This region is expected to maintain its position during the forecast period because of the presence of several leading biopharmaceuticals and biotechnology companies in this region

Asia Pacific region is projected to be the fastest-growing segment over the study period, due to rapidly booming biotechnology industry and comparatively less stringent regulations for biologics development in APAC region

Some of the key players include GE Healthcare; Thermo Fisher Scientific, Inc.; Sartorius AG; Merck KGaA; Pall Corp.; Eppendorf AG; Cellab GmbH; INTEGRA Biosciences AG; and FiberCell Systems Inc.
PLEASE NOTE: This report will be completed after order and will take approximately 1-2 business days after the confirmation of payment.
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Cellab GmbH
  • Eppendorf AG
  • GE Healthcare
  • INTEGRA Biosciences AG
  • Merck KGaA
  • Pall Corp.
  • MORE
1 Research Methodology
1.1 Country Wise Market: Base Estimates
1.2 Global Market: CAGR Calculation
1.3 Region Based Segment Share Calculation
1.4 Research Scope & Assumptions
1.5 List of Data Sources
1.5.1 Data for primary interviews, by sources
1.5.2 Data for primary interviews, by region

2 Executive Summary
2.1 Market Snapshot

3 Antibody Production Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Increased demand for therapeutic antibodies
3.2.2 Increasing investment in R&D
3.2.3 Rising adoption of targeted therapy
3.3 Market Restraint Analysis
3.3.1 Intense competition among vendors
3.3.2 Stringent government regulations
3.4 Key Opportunities Prioritized
3.4.1 Key opportunities prioritized, by process
3.4.2 Key opportunities prioritized, by type
3.4.3 Key opportunities prioritized, by end-use
3.5 Antibody Production - SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
3.6 Industry Analysis - Porter’s
3.7 Antibody Production Market: Market Position Analysis, 2016

4 Antibody Production Market: Process Estimates & Trend Analysis
4.1 Antibody Production Market: Process Movement Analysis
4.2 Upstream processing
4.2.1 Upstream processing market, 2014 - 2025 (USD Million)
4.2.2 Bioreactors
4.2.2.1 Bioreactors market, 2014 - 2025 (USD Million)
4.2.2.2 Large-scale bioreactors
4.2.2.2.1 Large-scale bioreactors market, 2014 - 2025 (USD Million)
4.2.2.3 Single-use bioreactors
4.2.2.3.1 Single-use bioreactors market, 2014 - 2025 (USD Million)
4.2.3 Consumables
4.2.3.1 Consumables market, 2014 - 2025 (USD Million)
4.2.3.2 Media
4.2.3.2.1 Media market, 2014 - 2025 (USD Million)
4.2.3.3 Buffers and reagents
4.2.3.3.1 Buffers and reagents market, 2014 - 2025 (USD Million)
4.3 Downstream processing
4.3.1 Downstream processing market, 2014 - 2025 (USD Million)
4.3.2 Chromatography systems
4.3.2.1 Chromatography systems market, 2014 - 2025 (USD Million)
4.3.3 Chromatography resins
4.3.3.1 Chromatography resins market, 2014 - 2025 (USD Million)
4.4 Filtration
4.4.1 Filtration market, 2014 - 2025 (USD Million)
4.4.2 Filtration systems
4.4.2.1 Filtration systems market, 2014 - 2025 (USD Million)
4.4.3 Filtration consumables and accessories
4.4.3.1 Filtration consumables and accessories market, 2014 - 2025 (USD Million)

5 Antibody Production Market: Type Estimates & Trend Analysis
5.1 Antibody Production Market: Type Movement Analysis
5.2 Polyclonal antibody
5.2.1 Polyclonal antibody market, 2014 - 2025 (USD Million)
5.3 Monoclonal antibody
5.3.1 Monoclonal antibody market, 2014 - 2025 (USD Million)
5.3.2 Murine monoclonal antibody
5.3.2.1 Murine monoclonal antibody market, 2014 - 2025 (USD Million)
5.3.3 Chimeric monoclonal antibody
5.3.3.1 Chimeric monoclonal antibody market, 2014 - 2025 (USD Million)
5.3.4 Humanized monoclonal antibody
5.3.4.1 Humanized monoclonal antibody market, 2014 - 2025 (USD Million)

6 Antibody Production Market: End-Use Estimates & Trend Analysis
6.1 Antibody Production Market: End-Use Movement Analysis
6.2 Pharmaceutical and biotechnology companies
6.2.1 Pharmaceutical and biotechnology companies market, 2014 - 2025 (USD Million)
6.3 Research laboratories
6.3.1 Research laboratories market, 2014 - 2025 (USD Million)
6.4 Others
6.4.1 Pharmaceutical and biotechnology companies market, 2014 - 2025 (USD Million)

7 Antibody Production Market: Regional Estimates & Trend Analysis, by Process, Type, End-Use
7.1 Antibody Production Market Share by Region, 2014 & 2025
7.2 North America
7.2.1 U.S.
7.2.1.1 U.S. antibody production market, by process, 2014 - 2025 (USD Million)
7.2.1.2 U.S. antibody production market, by type, 2014 - 2025 (USD Million)
7.2.1.3 U.S. antibody production market, by end-use, 2014 - 2025 (USD Million)
7.2.2 Canada
7.2.2.1 Canada antibody production market, by process, 2014 - 2025 (USD Million)
7.2.2.2 Canada antibody production market, by type, 2014 - 2025 (USD Million)
7.2.2.3 Canada antibody production market, by end-use, 2014 - 2025 (USD Million)
7.3 Europe
7.3.1 Germany
7.3.1.1 Germany antibody production market, by process, 2014 - 2025 (USD Million)
7.3.1.2 Germany antibody production market, by type, 2014 - 2025 (USD Million)
7.3.1.3 Germany antibody production market, by end-use, 2014 - 2025 (USD Million)
7.3.2 UK
7.3.2.1 UK antibody production market, by process, 2014 - 2025 (USD Million)
7.3.2.2 UK antibody production market, by type, 2014 - 2025 (USD Million)
7.3.2.3 UK antibody production market, by end-use, 2014 - 2025 (USD Million)
7.4 Asia Pacific
7.4.1 Japan
7.4.1.1 Japan antibody production market, by process, 2014 - 2025 (USD Million)
7.4.1.2 Japan antibody production market, by type, 2014 - 2025 (USD Million)
7.4.1.3 Japan antibody production market, by end-use, 2014 - 2025 (USD Million)
7.4.2 China
7.4.2.1 China antibody production market, by process, 2014 - 2025 (USD Million)
7.4.2.2 China antibody production market, by type, 2014 - 2025 (USD Million)
7.4.2.3 China antibody production market, by end-use, 2014 - 2025 (USD Million)
7.4.3 India
7.4.3.1 India antibody production market, by process, 2014 - 2025 (USD Million)
7.4.3.2 India antibody production market, by type, 2014 - 2025 (USD Million)
7.4.3.3 India antibody production market, by end-use, 2014 - 2025 (USD Million)
7.5 Latin America
7.5.1 Brazil
7.5.1.1 Brazil antibody production market, by process, 2014 - 2025 (USD Million)
7.5.1.2 Brazil antibody production market, by type, 2014 - 2025 (USD Million)
7.5.1.3 Brazil antibody production market, by end-use, 2014 - 2025 (USD Million)
7.5.2 Mexico
7.5.2.1 Mexico antibody production market, by process, 2014 - 2025 (USD Million)
7.5.2.2 Mexico antibody production market, by type, 2014 - 2025 (USD Million)
7.5.2.3 Mexico antibody production market, by end-use, 2014 - 2025 (USD Million)
7.6 MEA
7.6.1 South Africa
7.6.1.1 South Africa antibody production market, by process, 2014 - 2025 (USD Million)
7.6.1.2 South Africa antibody production market, by type, 2014 - 2025 (USD Million)
7.6.1.3 South Africa antibody production market, by end-use, 2014 - 2025 (USD Million)

8 Competitive Landscape
8.1 Company Profiles
8.1.1 GE Healthcare
8.1.1.1 Company overview
8.1.1.2 Financial performance
8.1.1.3 Product benchmarking
8.1.1.4 Strategic initiatives
8.1.2 Thermo Fisher Scientific, Inc.
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 Product benchmarking
8.1.2.4 Strategic initiatives
8.1.3 Sartorius AG
8.1.3.1 Company overview
8.1.3.2 Financial performance
8.1.3.3 Product benchmarking
8.1.3.4 Strategic initiatives
8.1.4 Merck KGaA
8.1.4.1 Company overview
8.1.4.2 Financial performance
8.1.4.3 Product benchmarking
8.1.4.4 Strategic initiatives
8.1.5 Pall Corp.
8.1.5.1 Company overview
8.1.5.2 Financial performance
8.1.5.3 Product benchmarking
8.1.5.4 Strategic initiatives
8.1.6 Pall Corp.
8.1.6.1 Company overview
8.1.6.2 Financial performance
8.1.6.3 Product benchmarking
8.1.6.4 Strategic initiatives
8.1.7 Eppendorf AG
8.1.7.1 Company overview
8.1.7.2 Financial performance
8.1.7.3 Product benchmarking
8.1.7.4 Strategic initiatives
8.1.8 Cellab GmbH
8.1.8.1 Company overview
8.1.8.2 Financial performance
8.1.8.3 Product benchmarking
8.1.8.4 Strategic initiatives
8.1.9 INTEGRA Biosciences AG
8.1.9.1 Company overview
8.1.9.2 Financial performance
8.1.9.3 Product benchmarking
8.1.9.4 Strategic initiatives
8.1.10 INTEGRA Biosciences AG
8.1.10.1 Company overview
8.1.10.2 Financial performance
8.1.10.3 Product benchmarking
8.1.10.4 Strategic initiatives

List of Tables

Table 1 Factors used in segment share estimation
Table 2 List of secondary data sources
Table 3 Primary interview details, by source
Table 4 Primary interview details, by region
Table 5 North America antibody production market, by country, 2014 - 2025 (USD Million)
Table 6 North America antibody production market, by process, 2014 - 2025 (USD Million)
Table 7 North America antibody production market, by type, 2014 - 2025 (USD Million)
Table 8 North America antibody production market, by end-use, 2014 - 2025 (USD Million)
Table 9 U.S. antibody production market, by process, 2014 - 2025 (USD Million)
Table 10 U.S. antibody production market, by type, 2014 - 2025 (USD Million)
Table 11 U.S. antibody production market, by end-use, 2014 - 2025 (USD Million)
Table 12 Canada antibody production market, by process, 2014 - 2025 (USD Million)
Table 13 Canada antibody production market, by type, 2014 - 2025 (USD Million)
Table 14 Canada antibody production market, by end-use, 2014 - 2025 (USD Million)
Table 15 Europe antibody production market, by country, 2014 - 2025 (USD Million)
Table 16 Europe antibody production market, by process, 2014 - 2025 (USD Million)
Table 17 Europe antibody production market, by type, 2014 - 2025 (USD Million)
Table 18 Europe antibody production market, by end-use, 2014 - 2025 (USD Million)
Table 19 Germany antibody production market, by process, 2014 - 2025 (USD Million)
Table 20 Germany antibody production market, by type, 2014 - 2025 (USD Million)
Table 21 Germany antibody production market, by end-use, 2014 - 2025 (USD Million)
Table 22 UK antibody production market, by process, 2014 - 2025 (USD Million)
Table 23 UK antibody production market, by type, 2014 - 2025 (USD Million)
Table 24 UK antibody production market, by end-use, 2014 - 2025 (USD Million)
Table 25 Asia Pacific antibody production market, by country, 2014 - 2025 (USD Million)
Table 26 Asia Pacific antibody production market, by process, 2014 - 2025 (USD Million)
Table 27 Asia Pacific antibody production market, by type, 2014 - 2025 (USD Million)
Table 28 Asia Pacific antibody production market, by end-use, 2014 - 2025 (USD Million)
Table 29 Japan antibody production market, by process, 2014 - 2025 (USD Million)
Table 30 Japan antibody production market, by type, 2014 - 2025 (USD Million)
Table 31 Japan antibody production market, by end-use, 2014 - 2025 (USD Million)
Table 32 China antibody production market, by process, 2014 - 2025 (USD Million)
Table 33 China antibody production market, by type, 2014 - 2025 (USD Million)
Table 34 China antibody production market, by end-use, 2014 - 2025 (USD Million)
Table 35 India antibody production market, by process, 2014 - 2025 (USD Million)
Table 36 India antibody production market, by type, 2014 - 2025 (USD Million)
Table 37 India antibody production market, by end-use, 2014 - 2025 (USD Million)
Table 38 Latin America antibody production market, by country, 2014 - 2025 (USD Million)
Table 39 Latin America antibody production market, by process, 2014 - 2025 (USD Million)
Table 40 Latin America antibody production market, by type, 2014 - 2025 (USD Million)
Table 41 Latin America antibody production market, by end-use, 2014 - 2025 (USD Million)
Table 42 Brazil antibody production market, by process, 2014 - 2025 (USD Million)
Table 43 Brazil antibody production market, by type, 2014 - 2025 (USD Million)
Table 44 Brazil antibody production market, by end-use, 2014 - 2025 (USD Million)
Table 45 Mexico antibody production market, by process, 2014 - 2025 (USD Million)
Table 46 Mexico antibody production market, by type, 2014 - 2025 (USD Million)
Table 47 Mexico antibody production market, by end-use, 2014 - 2025 (USD Million)
Table 48 MEA antibody production market, by country, 2014 - 2025 (USD Million)
Table 49 MEA antibody production market, by process, 2014 - 2025 (USD Million)
Table 50 MEA antibody production market, by type, 2014 - 2025 (USD Million)
Table 51 MEA antibody production market, by end-use, 2014 - 2025 (USD Million)
Table 52 South Africa antibody production market, by process, 2014 - 2025 (USD Million)
Table 53 South Africa antibody production market, by type, 2014 - 2025 (USD Million)
Table 54 South Africa antibody production market, by end-use, 2014 - 2025 (USD Million)

List of Figures

Figure 1 Primary interviews, by sources
Figure 2 Primary interviews, by region
Figure 3 Market summary
Figure 4 Market trends & outlook
Figure 5 Market segmentation & scope
Figure 6 Market driver relevance analysis (current & future impact)
Figure 7 Key opportunities prioritized, by process
Figure 8 Key opportunities prioritized, by type
Figure 9 Key opportunities prioritized, by end-use
Figure 10 SWOT analysis, by factor (political & legal, economic and technological)
Figure 11 Porter’s five forces analysis
Figure 12 Antibody production market: Market position analysis, 2016
Figure 13 Antibody production market process outlook: Key takeaways
Figure 14 Antibody production market: Process movement analysis
Figure 15 Upstream processing market, 2014 - 2025 (USD Million)
Figure 16 Bioreactors market, 2014 - 2025 (USD Million)
Figure 17 Large-scale bioreactors market, 2014 - 2025 (USD Million)
Figure 18 Single-use bioreactors market, 2014 - 2025 (USD Million)
Figure 19 Consumables market, 2014 - 2025 (USD Million)
Figure 20 Media market, 2014 - 2025 (USD Million)
Figure 21 Buffers and reagents market, 2014 - 2025 (USD Million)
Figure 22 Downstream processing market, 2014 - 2025 (USD Million)
Figure 23 Chromatography systems market, 2014 - 2025 (USD Million)
Figure 24 Chromatography resins market, 2014 - 2025 (USD Million)
Figure 25 Filtration market, 2014 - 2025 (USD Million)
Figure 26 Filtration systems market, 2014 - 2025 (USD Million)
Figure 27 Filtration consumables and accessories market, 2014 - 2025 (USD Million)
Figure 28 Antibody production market type outlook: Key takeaways
Figure 29 Antibody production market: Type movement analysis
Figure 30 Polyclonal antibody market, 2014 - 2025 (USD Million)
Figure 31 Monoclonal antibody market, 2014 - 2025 (USD Million)
Figure 32 Murine monoclonal antibody market, 2014 - 2025 (USD Million)
Figure 33 Chimeric monoclonal antibody market, 2014 - 2025 (USD Million)
Figure 34 Humanized monoclonal antibody market, 2014 - 2025 (USD Million)
Figure 35 Antibody production market end-use outlook: Key takeaways
Figure 36 Antibody production market: End-use movement analysis
Figure 37 Pharmaceutical and biotechnology companies market, 2014 - 2025 (USD Million)
Figure 38 Research laboratories market, 2014 - 2025 (USD Million)
Figure 39 Other end-use market, 2014 - 2025 (USD Million)
Figure 40 Regional market place: Key takeaways
Figure 41 Regional outlook, 2016 & 2025
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
  • GE Healthcare
  • Thermo Fisher Scientific, Inc.
  • Sartorius AG
  • Merck KGaA
  • Pall Corp.
  • Eppendorf AG
  • Cellab GmbH
  • INTEGRA Biosciences AG
Note: Product cover images may vary from those shown
5 of 6
The methodology is available for download below.
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll